These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6153892)

  • 1. The distinction between the exposed regions and the buried regions of apoproteins in high density lipoproteins by their reactivities with pronase.
    Jeng I; Steelman R; Reilly P; Jeng Y; Schonfeld G
    Biochem Biophys Res Commun; 1980 Feb; 92(3):876-82. PubMed ID: 6153892
    [No Abstract]   [Full Text] [Related]  

  • 2. The antigenic structure of apolipoprotein A-I in human high density lipoproteins. Radioimmunoassay using surface-specific antibodies.
    Mao SJ; Miller JP; Gotto AM; Sparrow JT
    J Biol Chem; 1980 Apr; 255(8):3448-53. PubMed ID: 6154052
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitation of the two major apoproteins of human high density lipoproteins by solid phase radioimmunoassay.
    Riesen WF; Mordasini RC; Middelhoff GW
    FEBS Lett; 1978 Jul; 91(1):35-9. PubMed ID: 208867
    [No Abstract]   [Full Text] [Related]  

  • 4. Conformational transitions in serum HDL apoproteins of hyperlipidaemic rabbits.
    Dhawan S; Nityanand S; Kappoor NK; Singh S
    Indian J Biochem Biophys; 1981 Oct; 18(5):326-8. PubMed ID: 7341410
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of lipid--protein interaction in the plasma lipoproteins: relationship of lipid-binding sites to antigenic sites in apolipoprotein A-II.
    Mao SJ; Sparrow JT; Gotto AM; Jackson RL
    Biochemistry; 1979 Sep; 18(18):3984-8. PubMed ID: 90518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Apoproteins C and E from very low and high density lipoproteins in men with dysalphalipoproteinemia].
    Shcherbakova IA; Gerasimova EN; Perova NV; Chernyshova NP
    Vopr Med Khim; 1982; 28(3):117-23. PubMed ID: 7101813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-peptides--new apoproteins of human high density lipoproteins induced by glucose infusions.
    Malmendier CL; Ameryckx JP
    Clin Chim Acta; 1981 Apr; 111(2-3):267-70. PubMed ID: 7226554
    [No Abstract]   [Full Text] [Related]  

  • 8. The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay.
    Schonfeld G; Pfleger B
    J Clin Invest; 1974 Aug; 54(2):236-46. PubMed ID: 4136225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI; Packman CH; Leddy JP
    J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the apolipoproteins of rat plasma lipoproteins.
    Swaney JB; Braithwaite F; Eder HA
    Biochemistry; 1977 Jan; 16(2):271-8. PubMed ID: 65178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of baboon plasma high-density lipoproteins and of their major apoproteins.
    Blaton V; Vercaemst R; Rosseneu M; Mortelmans J; Jackson RL; Gotto AM; Peeters H
    Biochemistry; 1977 May; 16(10):2157-63. PubMed ID: 193555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance.
    Hoffman JS; Benditt EP
    J Clin Invest; 1983 Apr; 71(4):926-34. PubMed ID: 6833494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma high density apolipoprotein A-I: effect of protein-protein interactions on the spontaneous formation of a lipid-protein recombinant.
    Massey JB; Gotto AM; Pownall HJ
    Biochem Biophys Res Commun; 1981 Mar; 99(2):466-74. PubMed ID: 6786293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition and metabolism of high-density lipoproteins.
    Schaefer EJ; Levy RI
    Prog Biochem Pharmacol; 1979; 15():200-15. PubMed ID: 224395
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioimmunoassay of apolipoprotein A-I of rat serum.
    Fainaru M; Havel RJ; Felker TE
    Biochim Biophys Acta; 1976 Sep; 446(1):56-68. PubMed ID: 184835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.
    Assmann G; Smootz E; Adler K; Capurso A; Oette K
    J Clin Invest; 1977 Mar; 59(3):565-75. PubMed ID: 190272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the plasma lipoprotein-apoproteins of guinea pigs in response to dietary cholesterol.
    Guo LS; Meng M; Hamilton RL; Ostwald R
    Biochemistry; 1977 Dec; 16(26):5807-12. PubMed ID: 201278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of high density lipoproteins in patients heterozygous for Tangier disease.
    Assmann G; Simantke O; Schaefer HE; Smootz E
    J Clin Invest; 1977 Nov; 60(5):1025-35. PubMed ID: 198431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.